These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21554167)

  • 21. Representation and analysis of molecular networks involving diseases and drugs.
    Kanehisa M
    Genome Inform; 2009 Oct; 23(1):212-3. PubMed ID: 20180276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomics for bioactivity assessment of natural products.
    Yuliana ND; Khatib A; Choi YH; Verpoorte R
    Phytother Res; 2011 Feb; 25(2):157-69. PubMed ID: 20658470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Strategies on the construction of high-quality microbial natural product library--a review].
    Bian J; Song F; Zhang L
    Wei Sheng Wu Xue Bao; 2008 Aug; 48(8):1132-7. PubMed ID: 18956767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thoughts and facts about antibiotics: where we are now and where we are heading.
    Bérdy J
    J Antibiot (Tokyo); 2012 Aug; 65(8):385-95. PubMed ID: 22511224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural products: a continuing source of novel drug leads.
    Cragg GM; Newman DJ
    Biochim Biophys Acta; 2013 Jun; 1830(6):3670-95. PubMed ID: 23428572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approaches to capturing and designing biologically active small molecules produced by uncultured microbes.
    Piel J
    Annu Rev Microbiol; 2011; 65():431-53. PubMed ID: 21682647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rare actinomycetes: a potential storehouse for novel antibiotics.
    Tiwari K; Gupta RK
    Crit Rev Biotechnol; 2012 Jun; 32(2):108-32. PubMed ID: 21619453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational approaches to natural-product-based drug design.
    Haustedt LO; Mang C; Siems K; Schiewe H
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):445-62. PubMed ID: 16889228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural products and Pharma 2011: strategic changes spur new opportunities.
    Carter GT
    Nat Prod Rep; 2011 Oct; 28(11):1783-9. PubMed ID: 21909580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioprospecting microbial natural product libraries from the marine environment for drug discovery.
    Liu X; Ashforth E; Ren B; Song F; Dai H; Liu M; Wang J; Xie Q; Zhang L
    J Antibiot (Tokyo); 2010 Aug; 63(8):415-22. PubMed ID: 20606699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs from hidden bugs: their discovery via untapped resources.
    Lefevre F; Robe P; Jarrin C; Ginolhac A; Zago C; Auriol D; Vogel TM; Simonet P; Nalin R
    Res Microbiol; 2008 Apr; 159(3):153-61. PubMed ID: 18375103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilizing the power of microbial genetics to bridge the gap between the promise and the application of marine natural products.
    Fortman JL; Sherman DH
    Chembiochem; 2005 Jun; 6(6):960-78. PubMed ID: 15880675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rediscovering natural products as a source of new drugs.
    Koehn FE; Carter GT
    Discov Med; 2005 Apr; 5(26):159-64. PubMed ID: 20704903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biodiversity, bioactive natural products and biotechnological potential of plant-associated endophytic actinobacteria.
    Qin S; Xing K; Jiang JH; Xu LH; Li WJ
    Appl Microbiol Biotechnol; 2011 Feb; 89(3):457-73. PubMed ID: 20941490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural products as a robust source of new drugs and drug leads: past successes and present day issues.
    Rishton GM
    Am J Cardiol; 2008 May; 101(10A):43D-49D. PubMed ID: 18474274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural products from cyanobacteria: Exploiting a new source for drug discovery.
    Sielaff H; Christiansen G; Schwecke T
    IDrugs; 2006 Feb; 9(2):119-27. PubMed ID: 16523402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodiversity as a source of anticancer drugs.
    Tan G; Gyllenhaal C; Soejarto DD
    Curr Drug Targets; 2006 Mar; 7(3):265-77. PubMed ID: 16515527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural products as catalysts for innovation: a pharmaceutical industry perspective.
    Schmitt EK; Moore CM; Krastel P; Petersen F
    Curr Opin Chem Biol; 2011 Aug; 15(4):497-504. PubMed ID: 21684800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.